Integrase Inhibitors for Feline Immunodeficiency Virus
Author Information
Author(s): Andrea Savarino, Mauro Pistello, Daniela D'Ostilio, Elisa Zabogli, Fabiana Taglia, Fabiola Mancini, Stefania Ferro, Donatella Matteucci, Laura De Luca, Maria Letizia Barreca, Alessandra Ciervo, Alba Chimirri, Massimo Ciccozzi, Mauro Bendinelli
Primary Institution: Istituto Superiore di Sanità
Hypothesis
Can integrase strand transfer inhibitors (INSTIs) effectively inhibit feline immunodeficiency virus (FIV) replication?
Conclusion
The study found that integrase inhibitors can effectively suppress FIV replication in vitro, suggesting potential for treating feline AIDS.
Supporting Evidence
- FIV integrase shares significant similarities with HIV-1 integrase.
- INSTIs designed for HIV-1 were effective against FIV in vitro.
- L-870,810 showed an EC50 in the low nanomolar range.
- Real-time PCR confirmed inhibition of FIV integration.
- FIV-infected cats are a viable model for studying HIV treatments.
Takeaway
This study shows that certain drugs can stop a virus that affects cats, similar to how some drugs work for humans with HIV.
Methodology
The study used molecular modeling, phylogenetic analysis, and in vitro testing of integrase inhibitors on FIV-infected feline cells.
Limitations
The study's findings need to be confirmed in vivo before clinical application.
Statistical Information
P-Value
0.0053
Confidence Interval
1.0–4.5 nM
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website